Funds and ETFs Pfizer, Inc.

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse 04:01:04 2024-05-08 pm EDT Pre-market 07:14:15 am
28.27 USD +1.80% Intraday chart for Pfizer, Inc. 27.86 -1.47%

ETFs positioned on Pfizer, Inc.

Name Weight AuM 1st Jan change Investor Rating
0.51% 29 M€ -.--% -
0.50% 23 M€ -.--% -
0.50% 786 M€ -.--%
0.50% 206 M€ -.--%
0.50% 0 M€ +11.27% -
0.45% 0 M€ +6.03% -
0.44% 0 M€ -1.76% -
0.43% 205 M€ -.--%
0.41% 0 M€ 0.00% -
0.41% 0 M€ +7.98% -
0.41% 14 M€ +16.19% -
0.39% 1 M€ +3.03% -
0.39% 0 M€ +8.23% -
0.38% 0 M€ +7.83% -
0.37% 0 M€ -1.48% -
0.37% 607 M€ +0.05% -
0.37% 1,166 M€ +0.26% -
0.33% 0 M€ +3.22% -
0.32% 0 M€ +6.12% -
0.30% 0 M€ +6.07% -
0.29% 0 M€ -.--% -
0.28% 0 M€ +5.46% -
0.28% 0 M€ +5.36% -
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.27 USD
Average target price
31.89 USD
Spread / Average Target
+12.81%
Consensus
  1. Stock Market
  2. Equities
  3. PFE Stock
  4. Funds and ETFs Pfizer, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW